Rena M. Conti, Ph.D., is an associate professor of Health Policy and Economics in the Department of Pediatrics, section of Hematology/Oncology, and the Department of Public Health Studies, at the University of Chicago. Dr. Conti is a 2006 graduate of the Harvard University Interfaculty Initiative in health policy and an elected member of the Conference on Research on Income and Wealth. She currently serves on the Government Affairs committee for the American Society of Clinical Oncology.
Dr. Conti's research is on the financing, organization, and regulation of medical care. She is an expert on the demand for, supply of, and pricing of prescription drugs, particularly those used to treat cancer and other "specialty" conditions.
She has published numerous studies estimating the annual costs of cancer treatments for patients and insurers. She has published several studies on what factors determine the pricing of branded and generic prescription drugs and the intended and unintended consequences of the 340B drug discount program. She is interested in using classic economic theory to guide policy making on the expansion of new drug development and patient access to existing drugs.